Acute Hospital, Community, and Indirect Costs of Stroke Associated With Atrial Fibrillation: Population-Based Study

BACKGROUND AND PURPOSE—No economic data from population-based studies exist on acute or late hospital, community, and indirect costs of stroke associated with atrial fibrillation (AF-stroke). Such data are essential for policy development, service planning, and cost-effectiveness analysis of new the...

Full description

Saved in:
Bibliographic Details
Published in:Stroke (1970) 2014-12, Vol.45 (12), p.3670-3674
Main Authors: Hannon, Niamh, Daly, Leslie, Murphy, Sean, Smith, Samantha, Hayden, Derek, Ní Chróinín, Danielle, Callaly, Elizabeth, Horgan, Gillian, Sheehan, Órla, Honari, Bahman, Duggan, Joseph, Kyne, Lorraine, Dolan, Eamon, Williams, David, Wiley, Miriam, Kelly, Peter J
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Atrial Fibrillation - complications
Atrial Fibrillation - economics
Biological and medical sciences
Cardiac dysrhythmias
Cardiology. Vascular system
Cost of Illness
Female
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Health Care Costs
Heart
Hospitals
Humans
Male
Medical sciences
Middle Aged
Nervous system (semeiology, syndromes)
Neurology
Residence Characteristics
Stroke - complications
Stroke - economics
Vascular diseases and vascular malformations of the nervous system
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND AND PURPOSE—No economic data from population-based studies exist on acute or late hospital, community, and indirect costs of stroke associated with atrial fibrillation (AF-stroke). Such data are essential for policy development, service planning, and cost-effectiveness analysis of new therapeutic agents. METHODS—In a population-based prospective study of incident and recurrent stroke treated in hospital and community settings, we investigated direct (healthcare related) and indirect costs for a 2-year period. Survival, disability, poststroke residence, and healthcare use were determined at 90 days, 1 year, and 2 years. Acute hospital cost was determined using a case-mix approach, and other costs using a bottom-up approach (2007 prices). RESULTS—In 568 patients ascertained in 1 year (2006), the total estimated 2-year cost was $33.84 million. In the overall sample, AF-stroke accounted for 31% (177) of patients, but a higher proportion of costs (40.5% of total and 45% of nursing home costs). On a per-patient basis compared with non–AF-stroke, AF-stroke was associated with higher total (P
ISSN:0039-2499
1524-4628
DOI:10.1161/STROKEAHA.114.005960